334 related articles for article (PubMed ID: 29071066)
1. The emerging role of PET imaging in dementia.
Iaccarino L; Sala A; Caminiti SP; Perani D
F1000Res; 2017; 6():1830. PubMed ID: 29071066
[TBL] [Abstract][Full Text] [Related]
2. FDG-PET and amyloid-PET imaging: the diverging paths.
Perani D
Curr Opin Neurol; 2014 Aug; 27(4):405-13. PubMed ID: 24927239
[TBL] [Abstract][Full Text] [Related]
3. Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting.
Perani D; Cerami C; Caminiti SP; Santangelo R; Coppi E; Ferrari L; Pinto P; Passerini G; Falini A; Iannaccone S; Cappa SF; Comi G; Gianolli L; Magnani G
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):499-508. PubMed ID: 26341365
[TBL] [Abstract][Full Text] [Related]
4. A new perspective for advanced positron emission tomography-based molecular imaging in neurodegenerative proteinopathies.
Perani D; Iaccarino L; Lammertsma AA; Windhorst AD; Edison P; Boellaard R; Hansson O; Nordberg A; Jacobs AH;
Alzheimers Dement; 2019 Aug; 15(8):1081-1103. PubMed ID: 31230910
[TBL] [Abstract][Full Text] [Related]
5. Molecular imaging of dementia.
Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
[TBL] [Abstract][Full Text] [Related]
6. Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of Dementia.
Eisenmenger LB; Huo EJ; Hoffman JM; Minoshima S; Matesan MC; Lewis DH; Lopresti BJ; Mathis CA; Okonkwo DO; Mountz JM
Semin Nucl Med; 2016 Jan; 46(1):57-87. PubMed ID: 26687858
[TBL] [Abstract][Full Text] [Related]
7. Brain Molecular Connectivity in Neurodegenerative Diseases: Recent Advances and New Perspectives Using Positron Emission Tomography.
Sala A; Perani D
Front Neurosci; 2019; 13():617. PubMed ID: 31258466
[TBL] [Abstract][Full Text] [Related]
8. [Amyloid Positron Emission Tomography in the Therapeutic Strategies for Alzheimer's Disease].
Ishii K
Brain Nerve; 2017 Jul; 69(7):809-818. PubMed ID: 28739995
[TBL] [Abstract][Full Text] [Related]
9. Imaging of neurodegenerative cognitive and behavioral disorders: practical considerations for dementia clinical practice.
Atri A
Handb Clin Neurol; 2016; 136():971-84. PubMed ID: 27430453
[TBL] [Abstract][Full Text] [Related]
10. PET/CT in diagnosis of dementia.
Berti V; Pupi A; Mosconi L
Ann N Y Acad Sci; 2011 Jun; 1228():81-92. PubMed ID: 21718326
[TBL] [Abstract][Full Text] [Related]
11. Role of positron emission tomography/computed tomography in dementia.
Hinds SR; Stocker DJ; Bradley YC
Radiol Clin North Am; 2013 Sep; 51(5):927-34. PubMed ID: 24010914
[TBL] [Abstract][Full Text] [Related]
12. [Biomarkers for dementia and other neurodegenerative diseases : Current developments].
Wiltfang J; Lewczuk P; Otto M
Nervenarzt; 2016 Dec; 87(12):1305-1309. PubMed ID: 27844089
[TBL] [Abstract][Full Text] [Related]
13. Imaging of neuroinflammation in dementia: a review.
Stefaniak J; O'Brien J
J Neurol Neurosurg Psychiatry; 2016 Jan; 87(1):21-8. PubMed ID: 26384512
[TBL] [Abstract][Full Text] [Related]
14. Target-specific PET probes for neurodegenerative disorders related to dementia.
Kadir A; Nordberg A
J Nucl Med; 2010 Sep; 51(9):1418-30. PubMed ID: 20810758
[TBL] [Abstract][Full Text] [Related]
15. PET/MR in dementia and other neurodegenerative diseases.
Barthel H; Schroeter ML; Hoffmann KT; Sabri O
Semin Nucl Med; 2015 May; 45(3):224-33. PubMed ID: 25841277
[TBL] [Abstract][Full Text] [Related]
16. Application of advanced brain positron emission tomography-based molecular imaging for a biological framework in neurodegenerative proteinopathies.
Perani D; Iaccarino L; Jacobs AH;
Alzheimers Dement (Amst); 2019 Dec; 11():327-332. PubMed ID: 31080871
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic impact of [
Zwan MD; Bouwman FH; Konijnenberg E; van der Flier WM; Lammertsma AA; Verhey FR; Aalten P; van Berckel BN; Scheltens P
Alzheimers Res Ther; 2017 Jan; 9(1):2. PubMed ID: 28093088
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease.
Scheltens P; Blennow K; Breteler MM; de Strooper B; Frisoni GB; Salloway S; Van der Flier WM
Lancet; 2016 Jul; 388(10043):505-17. PubMed ID: 26921134
[TBL] [Abstract][Full Text] [Related]
19. [Contribution of molecular imaging research to innovative drug development].
Shimada H
Rinsho Shinkeigaku; 2014; 54(12):1174-7. PubMed ID: 25672737
[TBL] [Abstract][Full Text] [Related]
20. Molecular imaging in dementia: Past, present, and future.
Laforce R; Soucy JP; Sellami L; Dallaire-Théroux C; Brunet F; Bergeron D; Miller BL; Ossenkoppele R
Alzheimers Dement; 2018 Nov; 14(11):1522-1552. PubMed ID: 30028955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
